As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.

eji2541-sup-0001-FigureS1.pdf228KFigure S1. Differences in the dose of Th17or Th1 cells in allograft and the levels of Th17 or Th1 cells by day 30 after transplantaton in patients with mild to moderate cGVHD, severe cGVHD and without cGVHD.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.